Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Nevro Corp    NVRO

NEVRO CORP (NVRO)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/10/2018 10/11/2018 10/12/2018 10/15/2018 10/16/2018 Date
49.64(c) 50.68(c) 52.86(c) 53.08(c) 55.09(c) Last
499 201 509 917 988 423 403 704 340 836 Volume
-4.11% +2.10% +4.30% +0.42% +3.79% Change
More quotes
Financials (USD)
Sales 2018 386 M
EBIT 2018 -30,8 M
Net income 2018 -39,6 M
Finance 2018 52,2 M
Yield 2018 -
Sales 2019 438 M
EBIT 2019 -1,93 M
Net income 2019 -9,08 M
Finance 2019 66,6 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 3,99x
EV / Sales2019 3,49x
Capitalization 1 592 M
More Financials
Company
Nevro Corp. engages in the provision of medical devices.It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain.The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood... 
More about the company
Surperformance© ratings of Nevro Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on NEVRO CORP
10/11NEVRO : to Report Operating Results for the Third Quarter 2018
PR
10/10NEVRO : The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline..
BU
10/09GLANCY PRONGAY & MURRAY LLP : Reminds Investors of the Deadline in the Class Act..
BU
10/05LAW OFFICES OF HOWARD G. SMITH : Announces the Filing of a Securities Class Acti..
BU
09/29NEVRO HOLDINGS ClaimsFiler Reminds Investors with Losses in Excess of $100,00..
BU
09/29NEVRO Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding..
PR
09/28GLANCY PRONGAY & MURRAY LLP : Announces the Filing of a Securities Class Action ..
BU
09/22NEVRO HOLDINGS CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,00..
PR
09/15NEVRO SHAREHOLDER ALERT BY FORMER LO : Kahn Swick & Foti, LLC Reminds Investors ..
BU
09/07Law Offices of Howard G. Smith Announces Investigation on Behalf of Nevro Cor..
BU
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
10/16STRATEGY : Has being defensive paid off since the 2008 crisis?
10/16ABBVIE : The Strategies AbbVie Employed to Protect Humira From Copycats
DJ
10/15ABBOTT LABORATORIES : Names Robert B. Ford President, Chief Operating Officer
DJ
10/15ConvaTec shares plunge on profit warning and CEO departure
RE
10/10MEDTRONIC : Gets Regulatory Approval for Insulin Pump
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
10/16TREND REVERSAL UP ALERT: $NVRO NEVRO CORP ? TradeIdeas via  
10/15DEADLINE ALERT- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of C.. 
10/15Leerink Swann Lowers Nevro Q4 2018 Earnings Estimates to ($0.02) EPS (Previou.. 
10/13SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Inves.. 
10/12Nevro to Report Operating Results for the Third Quarter 2018  
More tweets
Qtime:42
News from SeekingAlpha
10/08Medical device makers in the red 
09/14Nevro down nearly another 6% 
08/17FDA OKs brain stimulator for obsessive compulsive disorder 
08/04Nevro (NVRO) CEO Rami Elghandour on Q2 2018 Results - Earnings Call Transcrip.. 
08/02Nevro misses by $0.04, beats on revenue 
Chart NEVRO CORP
Duration : Period :
Nevro Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEVRO CORP
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 72,0 $
Spread / Average Target 36%
EPS Revisions
Managers
NameTitle
Rami Elghandour President, Chief Executive Officer & Director
Michael F. DeMane Chairman
Patrick Schmitz Vice President-Operations
Andrew H. Galligan Chief Financial Officer
Andre Walker Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
NEVRO CORP-23.12%1 592
MEDTRONIC PLC17.26%127 880
BAXTER INTERNATIONAL10.23%38 066
ALIGN TECHNOLOGY42.86%26 305
ZIMMER BIOMET HOLDINGS2.35%25 090
TERUMO CORP18.40%22 417